Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2012 Feb 15;2:CD009665. doi: 10.1002/14651858.CD009665

Analysis 2.8. Comparison 2 Subcutaneous sumatriptan 6 mg versus placebo, Outcome 8 Relief of functional disability.

Review: Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults

Comparison: 2 Subcutaneous sumatriptan 6 mg versus placebo

Outcome: 8 Relief of functional disability

graphic file with name emss-58494-t0021.jpg

(1) Data from Study 1 and Study 2 pooled

(2) Data from Study 1 and Study 2 pooled